Course Provider
Learning Objectives
Define biosimilars and differentiate them from small molecule drugs and generic products
Identify when a biosimilar can be substituted for its reference biologic product
Explain the concept of interchangeability
Describe Inflammatory Bowel Disease (IBD) and its potential relationship to colorectal cancer
Articulate current guidelines for the use of biosimilars in the treatment of IBD and colorectal cancer
Describe biosimilars in the pipeline for the treatment of IBD and colorectal cancer